Ann: NTI Secures Option to Cannabis Strains Targeting Autism, page-5

ROFLMAO!

I have a mental image of my Uncle Bruce lying back on his chaise longue back in the '60s with his headphones on, smoking a reefer, and visibly quivering with the intensity of the auditory experience!

On a more serious note, this effectively sends Neurotech back to square 1 as a med-tech R&D operation: plants with elevated levels of cannabinoids where there is "potential for these to target specific neurological disorders".

Three years from here to human trials. Five years to having the product on the market. Lots of opportunities for failure in toxicity and efficacy trials.